Covered recipient · General Payments record
DARRYL A GREEN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$4,773.58
- Reported across 255 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $769.23 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $568.24 | 23 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $59.57 | 3 |
| Lilly USA, LLC | $47.82 | 2 |
| Amgen Inc. | $19.96 | 1 |
| Novo Nordisk AS | $17.29 | 1 |
| Phathom Pharmaceuticals, Inc. | $14.26 | 1 |
| GlaxoSmithKline, LLC. | $14.19 | 1 |
| Astellas Pharma US Inc | $14.04 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $13.86 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.14 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103832596 | CMS |
| ABBVIE INC. | $16.21 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103832598 | CMS |
| ABBVIE INC. | $33.28 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103832600 | CMS |
| ABBVIE INC. | $32.74 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103832602 | CMS |
| ABBVIE INC. | $17.09 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103832604 | CMS |
| ABBVIE INC. | $25.13 | 02/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103832606 | CMS |
| ABBVIE INC. | $25.22 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103832608 | CMS |
| ABBVIE INC. | $16.44 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103832610 | CMS |
| ABBVIE INC. | $31.52 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103832612 | CMS |
| ABBVIE INC. | $32.14 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103832614 | CMS |
| ABBVIE INC. | $18.68 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103832616 | CMS |
| ABBVIE INC. | $15.16 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103832618 | CMS |
| ABBVIE INC. | $29.91 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103832620 | CMS |
| ABBVIE INC. | $17.89 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103832622 | CMS |
| ABBVIE INC. | $27.59 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103832624 | CMS |
| ABBVIE INC. | $29.84 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103832626 | CMS |
| ABBVIE INC. | $6.63 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103832628 | CMS |
| ABBVIE INC. | $33.97 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103832630 | CMS |
| ABBVIE INC. | $16.10 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103832632 | CMS |
| ABBVIE INC. | $32.56 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103832634 | CMS |
| ABBVIE INC. | $31.95 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103832636 | CMS |
| ABBVIE INC. | $31.78 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103832638 | CMS |
| ABBVIE INC. | $34.27 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103832640 | CMS |
| Amgen Inc. | $19.96 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111588830 | CMS |
| Astellas Pharma US Inc | $14.04 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139313192 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $13.86 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086267697 | CMS |
| GlaxoSmithKline, LLC. | $14.19 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116567608 | CMS |
| Lilly USA, LLC | $25.50 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136148522 | CMS |
| Lilly USA, LLC | $22.32 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136146047 | CMS |
| Novartis Pharmaceuticals Corporation | $17.98 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086896689 | CMS |
| Novartis Pharmaceuticals Corporation | $18.13 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086896697 | CMS |
| Novartis Pharmaceuticals Corporation | $23.46 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086896695 | CMS |
| Novo Nordisk Inc | $17.29 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096588739 | CMS |
| Phathom Pharmaceuticals, Inc. | $14.26 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151067625 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.